替米沙坦对病毒性心肌炎小鼠的心肌保护作用研究

Effect of telmisartan on protection of myocardia of mice with viral myocarditis

  • 摘要: 目的 探究冠心病患者医院感染病原菌分布与相关危险因素,制定预防措施,以降低医院感染率。方法 选择2012年2月-2014年12月医院住院冠心病患者1 220例,收集患者临床资料进行分析,对医院感染患者分泌物进行细菌培养,分析冠心病患者医院感染的病原菌分布及相关危险因素。数据分析采用SPSS18.0进行统计处理。结果 1 220例患者医院感染136例,感染率11.15%,感染部位主要是呼吸道占43.38%、腹腔占27.21%、消化道占11.03%;共培养出病原菌140株,主要为肺炎克雷伯菌37株占26.43%、大肠埃希菌26株占18.57%、鲍氏不动杆菌21株占15.00%及金黄色葡萄球菌17株占12.14%为主;logistic回归分析发现,年龄、合并基础疾病、抗菌药物使用、住院时间及侵入性操作是冠心病患者医院感染的危险因素(P<0.05)。结论 提高冠心病患者自身免疫力,冠心病与基础疾病同时治疗,减少侵入性操作、缩短住院时间、合理使用抗菌药物,针对医院感染危险因素给予适宜的干预,控制冠心病患者医院感染发生。

     

    Abstract: OBJECTIVE To explore the distribution of pathogens causing nosocomial infections in patients with coronary heart disease, analyze the related risk factors, and put forward the prevention measures so as to reduce the incidence of the nosocomial infections. METHODS A total of 1 220 patients with coronary heart disease who were hospitalized from Feb 2012 to Dec 2014 were enrolled in the study, then the clinical data of the patients were analyzed, the bacterial culture was carried out for the secretion specimens obtained from the patients with nosocomial infections, the distribution of pathogens causing the nosocomial infections and the related risk factors were observed, and the statistical analysis of data was performed with the use of SPSS 18.0 software. RESULTS Of the 1 220 patients, 136 patients had nosocomial infections with the infection rate 11.15%, of whom 43.38% had respiratory tract infections, 27.21% had abdominal infections, and 11.03% had gastrointestinal tract infections. Totally 140 strains of pathogens were isolated, of which 37 (26.43%) were Klebsiella pneumoniae, 26 (18.57%) were Escherichia coli, 21 (15.00%) were Acinetobacter baumannii, and 17 (12.14%) were Staphylococcus aureus. The logistic regression analysis showed that the risk factors for the nosocomial infections in the patients with coronary heart disease included the age, complication of underlying diseases, use of antibiotics, length of hospital stay, and invasive operation (P<0.05). CONCLUSION It is an effective way to improve the immunity of the coronary heart disease patients of their own, simultaneously treat the coronary heart disease and underlying diseases, reduce invasive procedures, shorten the length of hospital stay, reasonably use antibiotics, and take appropriate interventions according to the risk factors for the nosocomial infections so as to control the nosocomial infections in the patients with coronary heart disease.

     

/

返回文章
返回